コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 gands, vascular cell adhesion molecule 1 and intercellular adhesion molecule 1.
2 orce-dependent kinetics of dissociation from intercellular adhesion molecule 1.
3 kocyte-endothelial adhesion via induction of intercellular adhesion molecule 1.
4 ectin, retinol-binding protein 4) or soluble intercellular adhesion molecule-1.
5 phages adhere to the beta(2) integrin ligand intercellular adhesion molecule-1.
6 geal fibroblasts after LIGHT stimulation via intercellular adhesion molecule-1.
7 senting cells was predominantly dependent on intercellular adhesion molecule-1.
8 n-6, vascular endothelial growth factor, and intercellular adhesion molecule-1.
9 "nonsticky" antigen-presenting cells lacking intercellular adhesion molecule-1.
10 radation, and decreases expression levels of intercellular adhesion molecule-1.
11 complement fragments iC3b and C3d but not to intercellular adhesion molecule-1.
13 The major ligands of LFA-1 include three intercellular adhesion molecules 1, 2, and 3 (ICAM 1, 2,
15 ons of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1, albeit less efficient
16 Ld plus costimulatory ligands, i.e. B7-1 and intercellular adhesion molecule-1 along with 2C T cell r
18 s and to enhanced cell-surface expression of intercellular adhesion molecule 1 and altered expression
19 stained positive for 2 inflammatory markers, intercellular adhesion molecule 1 and interleukin 8.
21 L oxidation and 2) a significant decrease in intercellular adhesion molecule 1 and OLR1 gene expressi
23 munoblots were used to measure expression of intercellular adhesion molecule 1 and the inducible form
24 electin, VCAM-1, and KC, while expression of intercellular adhesion molecule 1 and TNF-alpha was supp
25 n the luminal surface, such as clustering of intercellular adhesion molecule 1 and vascular cell adhe
26 derived from clustering of apically disposed intercellular adhesion molecule 1 and vascular cell adhe
27 egulation of the cellular adhesion molecules Intercellular Adhesion Molecule 1 and Vascular Cell Adhe
28 apitulated when a combination of recombinant intercellular adhesion molecule 1 and vascular cell adhe
29 dies against Macrophage-1 antigen (Mac-1) or intercellular adhesion molecule 1 and were reproduced in
31 endothelial cells had higher levels of ICAM (intercellular adhesion molecule)-1 and TF expression fol
32 h-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 and adjusted for these
34 [sRAGE]) and endothelial biomarkers (soluble intercellular adhesion molecule-1 and endocan [full-leng
35 ession in G2A(-/-) ECs significantly reduced intercellular adhesion molecule-1 and endothelial select
36 ubset of venules that express high levels of intercellular adhesion molecule-1 and low levels of cave
37 ar endothelial growth factor), and invasion (intercellular adhesion molecule-1 and matrix metalloprot
38 n, including the metastasis-related proteins intercellular adhesion molecule-1 and urokinase-type pla
41 A1 exon skipping mutations had higher plasma intercellular adhesion molecule-1 and vascular cell adhe
42 , CCL5, and CCL20 and the adhesion molecules intercellular adhesion molecule-1 and vascular cell adhe
43 re, CB2R agonists decreased the induction of intercellular adhesion molecule-1 and vascular cell adhe
44 derived from clustering of apically disposed intercellular adhesion molecule-1 and vascular cell adhe
45 alpha receptor II) and endothelial function (intercellular adhesion molecule-1 and vascular cell adhe
46 ities in soluble adhesion molecules (soluble intercellular adhesion molecule-1 and vascular cellular
47 ng slow neutrophil rolling on E-selectin and intercellular adhesion molecule-1 and were unable to pho
48 e vascular cell adhesion molecule-1, soluble intercellular adhesion molecule-1) and immune (soluble t
49 uced pulmonary adhesion molecule expression (intercellular adhesion molecule-1) and tissue infiltrati
50 n), invasion (matrix metalloproteinase-9 and intercellular adhesion molecule-1), and angiogenesis (va
51 phaIIbbeta3 with endothelial alphavbeta3 and intercellular adhesion molecule 1, and (3) a stimulatory
52 4 BCC tumor mRNA markers (CD25, CD3epsilon, intercellular adhesion molecule 1, and CD68) that have b
53 lpha, interleukin (IL)-1beta, IL-6, KC/IL-8, intercellular adhesion molecule 1, and cluster of differ
54 active protein, adiponectin, leptin, soluble intercellular adhesion molecule 1, and E-selectin all fe
55 re of multiple markers [interleukin-6, t-PA, intercellular adhesion molecule 1, and lipoprotein(a)] p
56 s showed increased interleukin (IL)-6, IL-8, intercellular adhesion molecule 1, and platelet endothel
57 elated adhesion molecules (e.g., P-selectin, intercellular adhesion molecule 1, and vascular cell adh
58 chemistry of eNOS, endothelin-1, P-selectin, intercellular adhesion molecule 1, and vascular cell adh
59 f adhesion molecules E-selectin, P-selectin, intercellular adhesion molecule 1, and vascular cell adh
60 lasma levels of tumor necrosis factor-alpha, intercellular adhesion molecule-1, and C-reactive protei
61 rom levels of C-reactive protein and soluble intercellular adhesion molecule-1, and endothelial funct
62 ecules, such as tumor necrosis factor-alpha, intercellular adhesion molecule-1, and MMP9 as well as a
63 ssion of vascular endothelial growth factor, intercellular adhesion molecule-1, and tumor necrosis fa
64 xpression of platelet-derived growth factor, intercellular adhesion molecule-1, and vascular adhesion
65 ntiation, respectively; the plasma levels of intercellular adhesion molecule 1; and CCR6 expression i
66 rs of endothelial adhesion (sICAM-1 [soluble intercellular adhesion molecule 1] and sVCAM-1 [soluble
67 M [vascular cell adhesion molecule-1], ICAM [intercellular adhesion molecule-1], and MCP1 [monocyte c
68 ion of NF-kappaB, which in turn up-regulated intercellular adhesion molecule 1 as evident from chroma
69 ference studies identified interleukin-6 and intercellular adhesion molecule-1 as key NF-kappaB targe
71 r alpha receptor II (B = 0.07, p < .01), and intercellular adhesion molecule-1 (B = 0.04, p < .05) le
72 e function-associated antigen 1) for ICAM-1 (intercellular adhesion molecule 1) but significantly low
73 in alpha(L)beta(2)-dependent slow rolling on intercellular adhesion molecule-1 by activating Src fami
74 also inhibited the TNF-induced induction of intercellular adhesion molecule-1, c-Myc, and c-Fos, all
75 efined as CD146(+)CD45(-)) exhibit increased intercellular adhesion molecule-1 (CD54) and Fas in resp
76 rosis factor-alpha levels as well as cardiac intercellular adhesion molecule-1, cytokine-induced neut
78 induced pulmonary inflammation, with altered intercellular adhesion molecule 1-dependent slow neutrop
79 unds of RW decreased serum concentrations of intercellular adhesion molecule-1, E-selectin, and IL-6
80 expression of NF-kappaB target genes VCAM-1, intercellular adhesion molecule-1, E-selectin, and tissu
81 rial loads were associated with higher serum intercellular adhesion molecule-1, E-selectin, and vascu
83 D showed increased endothelial inflammation (intercellular adhesion molecule 1 expression) and increa
84 -1 displayed an attenuated interleukin-6 and intercellular adhesion molecule 1 expression, resulting
86 ced tumor necrosis factor (TNF)alpha-induced intercellular adhesion molecule-1 expression and attenua
87 eling-positive cells, TNF-alpha release, and intercellular adhesion molecule-1 expression compared wi
88 tes monocyte adhesion by inducing VCAM-1 and intercellular adhesion molecule-1 expression in endothel
89 ase products and IL-10 and reduced CD11b and intercellular adhesion molecule-1 expression on neutroph
90 leased platelet miR-320b on endothelial cell intercellular adhesion molecule-1 expression was shown.
91 reased vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, and neutro
93 anism and induced an increase in endothelial intercellular adhesion molecule-1 expression, production
94 helial vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression, reduced in
96 treatment failed to inhibit TNFalpha-induced intercellular adhesion molecule-1 expression, treatment
101 selectin, vascular cell adhesion molecule-1, intercellular adhesion molecule-1, fibrinogen-like prote
102 ges have been assumed to mediate adhesion to intercellular adhesion molecule-1 for T-cell conjugation
103 g receptors DC-SIGN (dendritic-cell-specific intercellular adhesion molecule 1-grabbing nonintegrin;
104 evirus A21, an EV with tropism for the human intercellular adhesion molecule 1 (hICAM-1), through ser
105 by this E3 ligase in the down regulation of intercellular adhesion molecule 1 (ICAM-1) and B7.2.
106 thelial growth factor (VEGF)), inflammatory (intercellular adhesion molecule 1 (ICAM-1) and cyclooxyg
107 human melanoma cell line (Lu1205) increased intercellular adhesion molecule 1 (ICAM-1) and E-selecti
109 of HTLV-1 p12(I)-mediated down-modulation of intercellular adhesion molecule 1 (ICAM-1) and ICAM-2.
110 the proinflammatory cell adhesion molecules intercellular adhesion molecule 1 (ICAM-1) and vascular
111 e endothelium and in adhesion to immobilized intercellular adhesion molecule 1 (ICAM-1) and vascular
112 ed protein kinases (MAPKs) and expression of intercellular adhesion molecule 1 (ICAM-1) and vascular
113 ction associated antigen 1 (LFA-1) binds the intercellular adhesion molecule 1 (ICAM-1) by its alpha(
114 In this study, the binding affinity of human intercellular adhesion molecule 1 (ICAM-1) chimera and l
115 ezrin/radixin/moesin (ERM) phosphorylation, intercellular adhesion molecule 1 (ICAM-1) clustering, a
116 recognition sequence AGCTCC (-39/-34) in the intercellular adhesion molecule 1 (ICAM-1) core promoter
117 Infected IL-17R-deficient corneas had low intercellular adhesion molecule 1 (ICAM-1) expression, a
118 and thereby dampens NF-kappaB activation and intercellular adhesion molecule 1 (ICAM-1) expression.
121 ascular cell adhesion molecule (VCAM-1), and intercellular adhesion molecule 1 (ICAM-1) on endothelia
122 to LLV was able to trigger the clustering of intercellular adhesion molecule 1 (ICAM-1) on endothelia
123 scribed as an inflammatory disease, in which intercellular adhesion molecule 1 (ICAM-1) plays a key r
124 re we show that HDL suppresses expression of intercellular adhesion molecule 1 (ICAM-1) through the t
125 shown to bind to several receptors, of which intercellular adhesion molecule 1 (ICAM-1) upregulation
128 tion between the two groups, lower levels of intercellular adhesion molecule 1 (ICAM-1) were observed
129 the NF-kappaB pathway instantly upregulates intercellular adhesion molecule 1 (ICAM-1) which binds i
131 ction also increased the cellular content of intercellular adhesion molecule 1 (ICAM-1), a molecule i
132 ow a group of PfEMP1 proteins interacts with intercellular adhesion molecule 1 (ICAM-1), allowing us
133 Surprisingly, the genetic deficiency of intercellular adhesion molecule 1 (ICAM-1), an establish
134 rogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-select
135 Leukocyte infiltration, improved levels of intercellular adhesion molecule 1 (ICAM-1), and oxidativ
136 tenuated the over expression of VEGF and the intercellular adhesion molecule 1 (ICAM-1), and reduced
137 gnificant in only 1 replication set included intercellular adhesion molecule 1 (ICAM-1), anti-LG3, am
138 "outside-in" signaling when bound to ligand intercellular adhesion molecule 1 (ICAM-1), but little i
139 vascular cell adhesion molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-1), E-selectin,
140 d inflammation: coagulation factor III (F3), intercellular adhesion molecule 1 (ICAM-1), interferon g
141 tu-like expression of cadherins, E-selectin, intercellular adhesion molecule 1 (ICAM-1), vascular cel
142 ance of a cellular adhesion protein known as intercellular adhesion molecule 1 (ICAM-1), which helps
143 We examined human effector T lymphocytes on intercellular adhesion molecule 1 (ICAM-1)-coated surfac
144 l host factors impacting protection included intercellular adhesion molecule 1 (ICAM-1)-dependent pol
145 the noninfected target cell in a gp120- and intercellular adhesion molecule 1 (ICAM-1)-dependent pro
146 cell morphology alterations, and crawling on intercellular adhesion molecule 1 (ICAM-1)-expressing ce
149 nt/beta-catenin signaling in AECs attenuated intercellular adhesion molecule 1 (ICAM-1)/vascular cell
150 d proteins HLA-A, HLA-B, and HLA-C antigens; intercellular adhesion molecule 1 (ICAM-1); S100; transc
151 nregulate MHC-I and PECAM-I but not B7.2 and intercellular adhesion molecule 1 (ICAM-I), consistent w
152 NOS), nuclear factor-kappa B (NF-kappaB) and intercellular adhesion molecule-1 (ICAM) (P < 0.001, res
153 of constitutive as well as IL-1beta-induced intercellular adhesion molecule-1 (ICAM-1) (of 55% and 5
154 endothelial adhesion molecules, particularly intercellular adhesion molecule-1 (ICAM-1) and a subsequ
155 ) to circulating pro-inflammatory cytokines, intercellular adhesion molecule-1 (ICAM-1) and acute cor
156 f these cells, concomitant with reduction of intercellular adhesion molecule-1 (ICAM-1) and diminishi
157 not Rac1, as critical for B cell adhesion to intercellular adhesion molecule-1 (ICAM-1) and IS format
158 contact points for the known HRV receptors, intercellular adhesion molecule-1 (ICAM-1) and low-densi
159 t3 interaction in correlation with increased intercellular adhesion molecule-1 (ICAM-1) and soluble-I
160 lls, we found that GPx-1 deficiency augments intercellular adhesion molecule-1 (ICAM-1) and vascular
161 ular endothelium on which ligands, including intercellular adhesion molecule-1 (ICAM-1) and vascular
162 otential of these cells through reduction of intercellular adhesion molecule-1 (ICAM-1) and vascular
163 tic cell line THP-1 to a surface coated with intercellular adhesion molecule-1 (ICAM-1) as a function
164 s serotypes, 90% (the major group) use human intercellular adhesion molecule-1 (ICAM-1) as their cell
165 udy was to identify mechanisms through which intercellular adhesion molecule-1 (ICAM-1) augments the
169 rombin signaling of NF-kappaB activation and intercellular adhesion molecule-1 (ICAM-1) expression in
170 tumor necrosis factor-alpha (TNF-alpha) and intercellular adhesion molecule-1 (ICAM-1) in aqueous hu
172 Herein, we describe the overexpression of intercellular adhesion molecule-1 (ICAM-1) in human TNBC
173 ntigen-1 (LFA-1) interaction with its ligand intercellular adhesion molecule-1 (ICAM-1) induces a gen
176 sion and display high spontaneous binding to intercellular adhesion molecule-1 (ICAM-1) ligand under
177 yte function-associated antigen-1 (LFA-1) to intercellular adhesion molecule-1 (ICAM-1) mediates leuk
179 tumor necrosis factor alpha (TNFalpha), and intercellular adhesion molecule-1 (ICAM-1) messenger RNA
180 n species accumulation, CD14 expression, and intercellular adhesion molecule-1 (ICAM-1) mRNA and prot
181 recognition of pMHC and the adhesion ligand intercellular adhesion molecule-1 (ICAM-1) on supported
183 called 3DNA coupled with antibodies against intercellular adhesion molecule-1 (ICAM-1), a glycoprote
185 NAME also blocked blast-induced increases in intercellular adhesion molecule-1 (ICAM-1), a molecule t
186 using polymer nanocarriers (NCs) targeted to intercellular adhesion molecule-1 (ICAM-1), an endotheli
187 PfEMP1 and human endothelial proteins CD36, intercellular adhesion molecule-1 (ICAM-1), and endothel
188 tor inhibitor-1, soluble E-selectin, soluble intercellular adhesion molecule-1 (ICAM-1), and soluble
189 scular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1), endothelial
190 elial migration mediated by a combination of intercellular adhesion molecule-1 (ICAM-1), vascular adh
191 t endothelial adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), vascular adh
192 pha by restraining the induced expression of intercellular adhesion molecule-1 (ICAM-1), vascular cel
193 sation requires selectin-mediated tethering, intercellular adhesion molecule-1 (ICAM-1)-dependent fir
194 ogo-B regulates leukocyte transmigration and intercellular adhesion molecule-1 (ICAM-1)-dependent sig
195 ated neutrophils, microglia/macrophages, and intercellular adhesion molecule-1 (ICAM-1)-positive bloo
207 urface proteins, including CD69, L-selectin, intercellular adhesion molecule-1 (ICAM-1, CD54), CD44,
208 or, neutrophil count, IL-1alpha, E-selectin, intercellular adhesion molecule 1 [ICAM-1], myeloperoxid
210 ng Raman-active molecules were conjugated to intercellular adhesion molecule 1- (ICAM-1-) specific mo
211 in T cells increased expression of IFNG and intercellular adhesion molecule 1 (ICAM1) and induced T-
212 , unlike amphiregulin and TNFRI, full-length intercellular adhesion molecule 1 (ICAM1) is released fr
213 pression of asparaginyl endopeptidase (AEP), intercellular adhesion molecule 1 (ICAM1), and ras-relat
214 monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule 1 (ICAM1), F4/80, plasmi
215 out mice originated from decreased levels of intercellular adhesion molecule 1 (ICAM1)/vascular cell
216 ster of differentiation 8a (Cd8a), Cd14, and intercellular adhesion molecule-1 (Icam1) by about two-f
217 in mice, these progenitor cells give rise to intercellular adhesion molecule-1 (ICAM1)/CD54-expressin
218 ells so modified expressed reduced levels of intercellular adhesion molecule-1 (ICAM1; CD54); blockad
219 IL-6], IL-8, IL-1alpha, CXCL1, CXCL2, CXCL3, intercellular adhesion molecule 1 [ICAM1]), chemoattract
221 or necrosis factor alpha, caspase-1 (CASP1), intercellular adhesion molecule 1, IL-10, heme oxygenase
223 activator [tPA]) and endothelial activation (intercellular adhesion molecule-1) in serial biopsies ob
224 the lymphocyte function-associated antigen 1-intercellular adhesion molecule 1 interaction, reduced T
225 signaling were quite distinct so that LFA-1/intercellular adhesion molecule-1 interaction exerted a
226 nd inflammatory markers [C-reactive protein, intercellular adhesion molecule-1, interleukin-6, and tu
227 th factor beta1 and beta2; thrombospondin 2; intercellular adhesion molecule 1; interleukin 6 [IL-6];
228 e tumor necrosis factor receptor II, soluble intercellular adhesion molecule 1, leptin, and adiponect
229 high-sensitivity C-reactive protein, soluble intercellular adhesion molecule-1, leptin, hemoglobin A(
230 antibody crosslinking or by crosslinking its intercellular adhesion molecule-1 ligand on the supporte
231 anulocyte colony-stimulating factor, soluble intercellular adhesion molecule 1, macrophage migration-
232 iomarkers strongly associated with death/MI: intercellular adhesion molecule-1, matrix metalloprotein
233 osis protein-2, cyclin D1, cyclooxygenase-2, intercellular adhesion molecule-1, matrix metalloprotein
234 Model 3 identified a set of 6 biomarkers (intercellular adhesion molecule-1, matrix metalloprotein
237 enofibrate also attenuated overexpression of intercellular adhesion molecule-1, monocyte chemoattract
238 ession of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, monocyte chemoattract
239 ses in vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 mRNA expression in the
240 ut reduced expression or secretion of T-bet, intercellular adhesion molecule-1, nucleotide-binding ol
241 cantly increased KC numbers via induction of intercellular adhesion molecule 1 on liver sinusoidal en
243 ls of plasma endothelial biomarkers (soluble intercellular adhesion molecule-1: OR, 1.58; 95% CI, 1.2
244 ine to 2-month follow-up in concentration of intercellular adhesion molecule-1 (P < .001), interleuki
245 vels correlated with serum levels of soluble intercellular adhesion molecule-1 (p = 0.001) and thioba
246 selectin, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, platelet endothelial
248 ecrosis factor receptor II (r=0.22), soluble intercellular adhesion molecule 1 (r=0.24), and leptin (
249 trast to most other rhinoviruses, which bind intercellular adhesion molecule 1 receptors via a capsid
250 ession for ACE2 and TMPRSS2, and for ICAM-1 (intercellular adhesion molecule 1) (rhinovirus receptor
251 ceptor-2, vascular cell adhesion molecule 1, intercellular adhesion molecule 1, selectins, and integr
253 t of BMI on inflammatory biomarkers [soluble intercellular adhesion molecule 1 (sICAM-1), high sensit
254 otein (hs-CRP), adiponectin, leptin, soluble intercellular adhesion molecule 1 (sICAM-1), soluble vas
255 the prospective association between soluble intercellular adhesion molecule-1 (sICAM-1) and cancer r
256 dence of proliferative DR (PDR), and soluble intercellular adhesion molecule-1 (sICAM-1) and TNF-alph
257 active protein (CRP), serum amyloid A (SAA), intercellular adhesion molecule-1 (sICAM-1) and vascular
258 vity C-reactive protein, fibrinogen, soluble intercellular adhesion molecule-1 (sICAM-1), homocystein
259 e measured levels of UA and soluble forms of intercellular adhesion molecule-1 (sICAM-1), vascular ce
260 dothelial activation (E-selectin and soluble intercellular adhesion molecule-1 [sICAM-1]), and thromb
261 crosis Factor receptor II [sTNFRII], soluble Intercellular Adhesion Molecule-1 [sICAM-1]), angiogenic
264 or-alpha receptor II, interleukin-6, soluble intercellular adhesion molecule 1, soluble vascular cell
265 th changes in von Willebrand factor, soluble intercellular adhesion molecule-1, soluble E-Selectin, P
266 levels of C-reactive protein, interleukin-6, intercellular adhesion molecule-1, soluble tumor necrosi
267 , angiopoietin-1 and angiopoietin-2, soluble intercellular adhesion molecule-1, soluble vascular cell
268 sitivity C-reactive protein, fibrinogen, and intercellular adhesion molecule-1, suggested that GlycA
269 microscopy and contrast-enhanced ultrasound, intercellular adhesion molecule-1-targeted and rhodamine
271 s were translatable in vivo, confirming that intercellular adhesion molecule-1-targeted and rhodamine
272 han antibodies to transferrin receptor-1 and intercellular adhesion molecule 1 (TfR-1 and ICAM-1).
273 or necrosis factor-alpha, interleukin-6, and intercellular adhesion molecule-1, than iron-overloaded
274 es produced greater levels of chemokines and intercellular adhesion molecule-1 that are associated wi
275 he capsid that caused a receptor switch from intercellular adhesion molecule-1 to CD155, leading to a
277 spleen tyrosine kinase and cell adhesion to intercellular adhesion molecule-1 under dynamic flow.
278 orrelated with IL-6, soluble TNF receptor 2, intercellular adhesion molecule 1, vascular adhesion mol
279 ld increase in the expression of E-selectin, intercellular adhesion molecule 1, vascular cell adhesio
280 e chemotactic protein-1, C-reactive protein, intercellular adhesion molecule-1, vascular cell adhesio
281 (tumor necrosis factor-alpha, interleukin-6, intercellular adhesion molecule-1, vascular cell adhesio
282 gamma), endothelial cell adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesio
283 ay and expression of cell adhesion molecules intercellular adhesion molecule-1, vascular cell adhesio
284 , enhanced expression of adhesion molecules (intercellular adhesion molecule-1, vascular cell adhesio
285 tion of retinal tumor necrosis factor-alpha, intercellular adhesion molecule-1, vascular cell adhesio
286 reduced or absent expression of P-selectin, intercellular adhesion molecule-1, vascular cell adhesio
287 ecreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesio
289 the expression of endothelial E-selectin and intercellular adhesion molecule 1 was decreased by eithe
290 and expression of constitutive and inducible intercellular adhesion molecule-1 was significantly high
292 g/L (P<0.0001), and median levels of soluble intercellular adhesion molecule-1 were 374 versus 333 ng
293 h-sensitivity C-reactive protein and soluble intercellular adhesion molecule-1 were added to multivar
294 n-8, monocyte chemoattactrant protein-1, and intercellular adhesion molecule-1 were analyzed after tr
295 n 6, tumor necrosis factor alpha and soluble intercellular adhesion molecule 1) were unsuitable for p
297 vascular cell adhesion molecule (VCAM)-1 and intercellular adhesion molecule-1, whereas NOR1 deficien
298 sinophils also showed enhanced expression of intercellular adhesion molecule 1, which depended on dir
299 s also associated with the overexpression of intercellular adhesion molecule 1, which is expressed on
300 increased progression risk, and increase in intercellular adhesion molecule 1 with vandetanib was as